Company Overview - Hyperion DeFi, Inc. is the first U.S. publicly listed company focused on building a strategic treasury around the HYPE token, integrating decentralized finance with traditional corporate treasury strategies [4] - The company aims to provide shareholders with simplified access to the Hyperliquid ecosystem, which is recognized as one of the fastest-growing and highest revenue-generating blockchains globally [4] Financial Events - Hyperion DeFi will host its second quarter 2025 earnings call on August 13, 2025, at 4:30 p.m. ET to review financial and operating results [1] - Participants can join the call via a domestic number (1-877-407-9039) or an international number (1-201-689-8470) using the conference code 13754799 [2] Upcoming Meetings - The company reminds investors to vote ahead of its Annual General Meeting scheduled for August 18, 2025 [3] Product Development - Hyperion DeFi is developing the Optejet User Filled Device (UFD), designed for various topical ophthalmic liquids, which may enhance patient outcomes due to its ease of use and potential for better compliance compared to standard eye drops [5] - The company is exploring strategic options for the Optejet technology [5]
Hyperion Defi to Report Second Quarter 2025 Results on Wednesday, August 13, 2025
Globenewswireยท2025-08-08 20:05